Parkinson’s startup Prevail raises $75M for gene therapy programs – FierceBiotech
FierceBiotech |
Parkinson's startup Prevail raises $75M for gene therapy programs
FierceBiotech OrbiMed-backed Prevail Therapeutics has launched a $75 million first-round financing that will help fund development of its gene therapy for Parkinson's disease (PD) and other programs. Prevail was set up last year by OrbiMed's co-head of private … Prevail Gets $75M For Parkinson's Gene Therapy, Bolstering NY Biotech Prevail grabs $75MA round in the hunt for new gene therapies to stop the destruction caused by Parkinson's Prevail Therapeutics Announces $75 Million Series A Financing to Advance Gene Therapies for Patients with … |
